Stay updated with breaking news from Translating Evidence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Working in partnership with FIGO, WHO and the United Nations Human Reproduction Programme (HRP) have a dedicated stream of 24+ sessions at the FIGO World Congress, addressing health and rights issues that affect women across the life course. Meet WHO technical experts at booth D-10 at the Paris Convention Centre and see the full programme, including the WHO specialist stream, here: https://figo2023.org/full-programme/
Tina Cascone, MD, Ben Levy, MD, and Sandip Patel, MD, offer insights into the treatment approach in patients with unresectable early-stage NSCLC who are unsuitable for consolidation durvalumab or who progress on consolidation durvalumab.
Sandip Patel, MD, shares his expert perspectives on novel combination consolidation immunotherapy regimens that are under evaluation in unresectable early-stage NSCLC.
Expert panelists discuss the characterization of patients with unresectable, early-stage NSCLC and what their standard treatment approach is for this patient population.
Ben Levy, MD, reviews the 5-year update and clinical implications of the PACIFIC study which evaluated consolidation immunotherapy in unresectable early-stage NSCLC.